Target Immobilization as a Strategy for NMR-Based Fragment Screening: Comparison of TINS, STD, and SPR for Fragment Hit Identification

被引:29
|
作者
Kobayashi, Masakazu [1 ]
Retra, Kim [2 ]
Figaroa, Francis [1 ]
Hollander, Johan G. [1 ]
Ab, Eiso [1 ]
Heetebrij, Robert J. [1 ]
Irth, Hubertus [2 ]
Siegal, Gregg [1 ,3 ]
机构
[1] ZoBio BV, NL-2333 CC Leiden, Netherlands
[2] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Fac Sci, Amsterdam, Netherlands
[3] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands
关键词
fragment-based drug discovery; NMR; TINS; saturation transfer difference NMR; surface plasmon resonance; DRUG DISCOVERY; LIGAND-BINDING; INHIBITORS; APPLICABILITY; SPECTROSCOPY; VALIDATION; DESIGN; RANGE;
D O I
10.1177/1087057110375614
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Fragment-based drug discovery (FBD) has become a widely accepted tool that is complementary to high-throughput screening (HTS) in developing small-molecule inhibitors of pharmaceutical targets. Because a fragment campaign can only be as successful as the hit matter found, it is critical that the first stage of the process be optimized. Here the authors compare the 3 most commonly used methods for hit discovery in FBD: high concentration screening (HCS), solution ligand-observed nuclear magnetic resonance (NMR), and surface plasmon resonance (SPR). They selected the commonly used saturation transfer difference (STD) NMR spectroscopy and the proprietary target immobilized NMR screening (TINS) as representative of the array of possible NMR methods. Using a target typical of FBD campaigns, the authors find that HCS and TINS are the most sensitive to weak interactions. They also find a good correlation between TINS and STD for tighter binding ligands, but the ability of STD to detect ligands with affinity weaker than 1 mM K-D is limited. Similarly, they find that SPR detection is most suited to ligands that bind with K-D better than 1 mM. However, the good correlation between SPR and potency in a bioassay makes this a good method for hit validation and characterization studies. (Journal of Biomolecular Screening 2010:978-989)
引用
收藏
页码:978 / 989
页数:12
相关论文
共 18 条
  • [1] PRACTICAL ASPECTS OF NMR-BASED FRAGMENT SCREENING
    Lepre, Christopher A.
    FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES, 2011, 493 : 219 - 239
  • [2] Ligand-Orientation Based Fragment Selection in STD NMR Screening
    Cala, Olivier
    Krimm, Isabelle
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) : 8739 - 8742
  • [3] NMR Screening and Hit Validation in Fragment Based Drug Discovery
    Campos-Olivas, Ramon
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (01) : 43 - 67
  • [4] NMR-based fragment screening and lead discovery accelerated by principal component analysis
    Andrew T. Namanja
    Jia Xu
    Haihong Wu
    Qi Sun
    Anup K. Upadhyay
    Chaohong Sun
    Steven R. Van Doren
    Andrew M. Petros
    Journal of Biomolecular NMR, 2019, 73 : 675 - 685
  • [5] NMR-based fragment screening and lead discovery accelerated by principal component analysis
    Namanja, Andrew T.
    Xu, Jia
    Wu, Haihong
    Sun, Qi
    Upadhyay, Anup K.
    Sun, Chaohong
    Van Doren, Steven R.
    Petros, Andrew M.
    JOURNAL OF BIOMOLECULAR NMR, 2019, 73 (12) : 675 - 685
  • [6] NMR-based Fragment Screening in a Minimum Sample but Maximum Automation Mode
    Berg, Hannes
    Martin, M. A. Wirtz
    Niesteruk, A.
    Richter, C.
    Sreeramulu, S.
    Schwalbe, H.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (172):
  • [7] Detection and Prevention of Aggregation-based False Positives in STD-NMR-based Fragment Screening
    Vom, Amelia
    Headey, Stephen
    Wang, Geqing
    Capuano, Ben
    Yuriev, Elizabeth
    Scanlon, Martin J.
    Simpson, Jamie S.
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2013, 66 (12) : 1518 - 1524
  • [8] NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds
    Yu, Jun-lan
    Chen, Tian-tian
    Zhou, Chen
    Lian, Fu-lin
    Tang, Xu-long
    Wen, Yi
    Shen, Jing-kang
    Xu, Ye-chun
    Xiong, Bing
    Zhang, Nai-xia
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (07) : 984 - 993
  • [9] Development of a Fragment-Based Screening Assay for the Focal Adhesion Targeting Domain Using SPR and NMR
    Alvarado, Carlos
    Stahl, Erik
    Koessel, Karissa
    Rivera, Andrew
    Cherry, Brian R.
    Pulavarti, Surya V. S. R. K.
    Szyperski, Thomas
    Cance, William
    Marlowe, Timothy
    MOLECULES, 2019, 24 (18):
  • [10] A combined fragment-based virtual screening and STD-NMR approach for the identification of E-cadherin ligands
    Vasile, Francesca
    Lavore, Francesca
    Gazzola, Silvia
    Vettraino, Chiara
    Parisini, Emilio
    Piarulli, Umberto
    Belvisi, Laura
    Civera, Monica
    FRONTIERS IN CHEMISTRY, 2022, 10